Risklick Logo

Develop the Clinical Trial Protocols of the Future Using AI

Protocol AI TM software is an end-to-end solution that enables experts to design and develop high-quality protocols and study plans rapidly and efficiently, helping companies shorten clinical development timelines and accelerate the delivery of new treatments to market.
50% Reduction
50% Reduction
in Protocol and Study Plans Development Time
20% Reduction
20% Reduction
in Protocol Amendments
40% Reduction
40% Reduction
in Protocol Implementation Time (EDC, eTMF)
Develop an Evidence-Based Protocol in 3 Steps
01
01
Explore
Analyze all study design elements systematically
02
02
Design
Optimize the study design by generating multiple scenarios
03
03
Develop
Develop protocols efficiently using our customized generative AI
Digital Protocol (ICH M11, USDM-Standard)
Digital Protocol (ICH M11, USDM-Standard)
Flexible and adaptable to any protocol template. Export options include Word, Excel, or JSON formats
Unique and Comprehensive Database
Unique and Comprehensive Database
Powered by a comprehensive database of over 800,000 clinical trials, accurately linked to publications, regulatory approvals, safety data, and various other sources
Streamlined Digital Data Flow (EDC, eTMF)
Streamlined Digital Data Flow (EDC, eTMF)
Easily integrates with electronic trial systems (e.g., EDC, eTMF) for efficient protocol implementation and change management

Reduce Time to Market with Protocol AI TM

Accelerate market access with optimized trial design and faster protocol and study plan creation and implementation. We are setting new standards for precision and excellence in the industry.
Develop Interconnected Study Documents with Protocol AI TMThe unique and comprehensive database behind Protocol AI TM brings all relevant evidence right to your fingertips. Design your study, explore different scenarios, and optimize your study design with ease. Our customized generative AI understands your design and requirements, automatically generating protocols and study plans tailored to your needs. The platform streamlines collaboration, enabling you and your team to efficiently finalize these documents in a short time. The interconnected protocol and study plans make changes simple and consistent.
Protocol AI
PartnersOur partners play a vital role in enhancing the capabilities and reach of our AI-driven solutions, ensuring the highest standards in clinical trial protocol development.
Logo 1
Logo 2
Logo 3
Logo 4
Logo 5
Logo 6
Logo 7
Logo 1
Logo 2
Logo 3
Logo 4
Logo 5
Logo 6
Logo 7
Executive Team
Poorya Amini
Poorya Amini
Founder & CEO
Quentin Haas
Quentin Haas
CSO
Philip Khlebnikov
Philip Khlebnikov
CTO
Florian Meer
Florian Meer
Head of Data Science
Joel Kühl
Joel Kühl
Head of Software Development
Advisory Board
PD. Dr. Sven Trelle
PD. Dr. SVEN TRELLE

Sven serves as the Vice Rector for Research and Innovation at the University of Bern. He possesses extensive expertise in the design and execution of innovative clinical trials, having previously held the position of Clinical Trial Unit Director for several years.

Dr. Beat Widler
Dr. BEAT WIDLER

Beat was the Initiator and former leader of the Roche Pharma Clinical Quality Risk Management (C-QRM) project for clinical development and pharmacovigilance for 25 years. Beat led more than 150 clinical trial center audits worldwide.

Prof. Dr. med. Matthias Egger
Prof. Dr. med. MATTHIAS EGGER

Matthias Egger is an internationally renowned epidemiologist with vast experience in clinical trial methodology, meta-analysis, and evidence generation. He is a professor of epidemiology at the University of Bern and the University of Bristol. Additionally, he serves as the President of the National Research Council at the Swiss National Science Foundation.

Dr. Ingrid Klingmann
Dr. INGRID KLINGMANN

Ingrid is a physician specialized in General Medicine, Clinical Pharmacology, and Pharmaceutical Medicine, with over 30 years of experience in various senior medical, operational, and managerial roles within the pharmaceutical industry, CROs, and clinical trial sites. Her focus revolves around clinical trial design and management, along with ethical and regulatory aspects.

NewsStay updated with the latest developments, breakthroughs, and insights in clinical research and AI technology. Explore our news section for the most recent updates and stories from our team and partners.